EPIC-Norfolk Publications Database

A 3-SNP gene risk score and a metabolic risk score both predict hypertriglyceridemia and cardiovascular disease risk.

Verbeek R, Oldoni F, Surendran RP, Zwinderman AH, Khaw KT, Stroes ESG, Wareham NJ, Boekholdt SM, and Dallinga-Thie GM

Journal of clinical lipidology. Jan 2018

(DOI : 10.1016/j.jacl.2019.02.005)

Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility.

Vergeer M, Boekholdt SM, Sandhu MS, Ricketts SL, Wareham NJ, Brown MJ, de Faire U, Leander K, Gigante B, Kavousi M, Hofman A, Uitterlinden AG, van Duijn CM, Witteman JC, Jukema JW, Schadt EE, van der Schoot E, Kastelein JJ, Khaw KT, Dullaart RP, van Tol A, Trip MD, and Dallinga-Thie GM

Circulation. Jul 2010

(DOI : 10.1161/CIRCULATIONAHA.109.912519)

Prolactin levels and the risk of future coronary artery disease in apparently healthy men and women.

Reuwer AQ, Twickler MT, Hutten BA, Molema FW, Wareham NJ, Dallinga-Thie GM, Bogorad RL, Goffin V, Smink-Bol M, Kastelein JJ, Boekholdt SM, and Khaw KT

Circulation. Cardiovascular genetics. Dec 2009

(DOI : 10.1161/CIRCGENETICS.109.853572)

Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT.

Vergeer M, Cohn DM, Boekholdt SM, Sandhu MS, Prins HM, Ricketts SL, Wareham NJ, Kastelein JJ, Khaw KT, Kamphuisen PW, and Dallinga-Thie GM

Atherosclerosis. Sep 2009

(DOI : 10.1016/j.atherosclerosis.2010.04.004)

Apolipoprotein A-II is inversely associated with risk of future coronary artery disease.

Birjmohun RS, Dallinga-Thie GM, Kuivenhoven JA, Stroes ES, Otvos JD, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, and Boekholdt SM

Circulation. Oct 2007

(DOI : 10.1161/CIRCULATIONAHA.107.704031)